{"id":15474,"date":"2012-09-26T10:30:00","date_gmt":"2012-09-26T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/farmaci-innovativi-disponibili-subito-per-i-pazienti-oncologici\/"},"modified":"2012-09-26T10:30:00","modified_gmt":"2012-09-26T08:30:00","slug":"farmaci-innovativi-disponibili-subito-per-i-pazienti-oncologici","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/farmaci-innovativi-disponibili-subito-per-i-pazienti-oncologici\/","title":{"rendered":"Innovative drugs available immediately for cancer patients"},"content":{"rendered":"<p>&nbsp;<\/p>\n<div class=\"thumb-dida box-img left foto-h-left\" title=\"\" style=\"margin: 0px 10px 10px 0px; padding: 0px; border: 1px solid rgb(156, 157, 157); outline: 0px; vertical-align: baseline; background-image: none; float: left; clear: both; display: inline; position: relative !important; width: 180px; \"><img decoding=\"async\" itemprop=\"image\" border=\"0\" align=\"left\" alt=\"\" title=\"\" src=\"http:\/\/images2.corriereobjects.it\/Media\/Foto\/2012\/09\/26\/Farmaci--180x140.jpg?v=20120926114317\" style=\"margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; vertical-align: baseline; display: block; float: none !important; height: auto !important; width: 180px !important; \" \/><\/div>\n<p><strong><span style=\"font-family: Verdana; \"><span style=\"background-color: rgba(255, 255, 255, 0); \">INNOVATIVE DRUGS AVAILABLE IMMEDIATELY FOR CANCER PATIENTS<\/span><\/span><\/strong><\/p>\n<p>source www. courier.it 09\/26\/2012<\/p>\n<p><span style=\"background-color: rgba(255, 255, 255, 0);\">MILAN - Innovative drugs for the treatment of tumors become immediately available for cancer patients thanks to the Balduzzi decree. It makes it known&nbsp;<a href=\"http:\/\/www.favo.it\/\" rel=\"nofollow noopener\" target=\"_blank\" style=\"margin: 0px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; text-decoration: none; \"><u>Honeycomb<\/u><\/a>&nbsp;(Italian federation of voluntary associations in oncology), whose general secretary Elisabetta Iannelli speaks of &quot;a real life-saving decree for cancer patients&quot;. The Balduzzi decree accepts one of the most important requests presented by Favo in recent months &quot;so that innovative drugs for the treatment of tumors are made immediately available in every part of Italy immediately after registration by AIFA at a national level, without having to wait for approval by the regional and provincial commissions and subsequent inclusion in the regional therapeutic handbooks&quot;.<\/span><\/p>\n<p style=\"margin: 1px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; \">&nbsp;<\/p>\n<p style=\"margin: 1px 0px 15px; padding: 0px; border: 0px; outline: 0px; vertical-align: baseline; \"><span style=\"background-color: rgba(255, 255, 255, 0);\"><b>HEALTH PROTECTION&nbsp;<\/b>\u2013 honeycomb e&nbsp;<a href=\"http:\/\/www.aiom.it\/default.asp\" rel=\"nofollow noopener\" target=\"_blank\" style=\"margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; vertical-align: baseline; \"><u>Aiom<\/u><\/a>&nbsp;(Italian Association of Medical Oncology) already in 2010 had reported the delays and discrepancies in access to innovative drugs in the various regions where in some cases, the postponement reached more than four years before a new therapy could actually be used by the patients. We had thus arrived at a first result with&nbsp;<a href=\"http:\/\/www.corriere.it\/salute\/sportello_cancro\/11_gennaio_23\/farmaci-innovativi_f277c9de-2554-11e0-9e30-00144f02aabc.shtml\" target=\"\" style=\"margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; vertical-align: baseline; \" rel=\"noopener\"><u>the approval of the agreement<\/u><\/a>&nbsp;on access to innovative medicines signed within the framework of the State-Regions Conference on 18 November 2010. But in 2012&nbsp;<a href=\"http:\/\/www.corriere.it\/salute\/sportello_cancro\/12_maggio_16\/farmaci-nuovi-anticancro-dove-disponibili_99aa5c92-9f2c-11e1-b258-f2fcbb76be58.shtml\" target=\"\" style=\"margin: 0px; padding: 0px; border: 0px; outline: 0px; font-style: inherit; vertical-align: baseline; \" rel=\"noopener\"><u>a subsequent analysis of the situation<\/u><\/a>, conducted by Favo and Aiom to monitor the application effectiveness of the State-Reasons agreement, while noting an improvement compared to 2011, highlighted the persistence of various critical issues in the real availability of the drug for patients. Now with this measure<\/p>","protected":false},"excerpt":{"rendered":"<p>&nbsp; FARMACI INNOVATIVI DISPONIBILI SUBITO PER I MALATI ONCOLOGICI fonte www. corriere.it 26\/09\/2012 MILANO &#8211; I farmaci innovativi per la cura dei tumori diventano immediatamente disponibili per i malati oncologici grazie al decreto Balduzzi. Lo rende noto la&nbsp;Favo&nbsp;(Federazione italiana delle associazioni di volontariato in oncologia), il cui segretario generale Elisabetta Iannelli parla di &laquo;un vero &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15474","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15474"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15474\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}